CMMB
Chemomab Therapeutics
CMMB
CMMB
17 hedge funds and large institutions have $1.47M invested in Chemomab Therapeutics in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$72.3K | |
| 2 | +$28.7K | |
| 3 | +$18.1K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$16.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$14.8K |
Top Sellers
| 1 | -$3.25K | |
| 2 | -$985 | |
| 3 | -$606 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$126 |